CA Patent

CA2326535A1 — Nucleosides with antiviral and anticancer activity

Assigned to University of Minnesota System · Expires 1999-10-07 · 27y expired

What this patent protects

The invention provides nucleosides of formulae (I), (II), (V) and (VII) as described in the specification which possess antiviral and anticancer activity. Treatment of breast cancer is a preferred embodiment.

USPTO Abstract

The invention provides nucleosides of formulae (I), (II), (V) and (VII) as described in the specification which possess antiviral and anticancer activity. Treatment of breast cancer is a preferred embodiment.

Drugs covered by this patent

Patent Metadata

Patent number
CA2326535A1
Jurisdiction
CA
Classification
—
Expires
1999-10-07
Drug substance claim
No
Drug product claim
No
Assignee
University of Minnesota System
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.